Evidence map›Paper›PMID 33225316›Full record

ReviewJTO clinical and research reports2020

Medicolegal Considerations in Multidisciplinary Cancer Care.

Pamela L Karas, Nicole M Rankin, Emily Stone

Abstract readReview
In one paragraph

Review in JTO clinical and research reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.Annals of oncology : official journal of the European Society for Medical Oncology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Building and Optimizing the Interdisciplinary Heart Team.Journal of the Society for Cardiovascular Angiography & Interventions
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Pamela L KarasKinghorn Cancer Centre, St Vincent's Hospital Sydney, University of New South Wales, Darlinghurst, New South Wales, Australia.
Nicole M RankinFaculty of Medicine and Health, University of Sydney, Sydney, Australia.
Emily StoneKinghorn Cancer Centre, St Vincent's Hospital Sydney, University of New South Wales, Darlinghurst, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health professionals participating in multidisciplinary team (MDT) cancer meetings may not be aware of their medicolegal obligations. This commentary aims to identify medicolegal issues concerning multidisciplinary cancer care and provides recommendations for future implementation. Predominant medicolegal issues related to MDT care were identified in the literature; these include patient consent and privacy at MDT meetings, professional liability, formal expression of dissenting views, and duty of care. Analysis of the literature prioritizes several recommendations for managing these issues. With limited precedent on which to base recommendations, this article identifies the formative evidence that may guide the management of these issues in future MDT practice.

Indexed as

CancerMedicolegalMultidisciplinaryOncologyTumor board

Identifiers

PMID33225316
PMCPMC7333617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.